IL6 and COVID-19: Based on the clinical cytokine profile across the studies in critical/deceased patients, serum IL-6 level is well established as a reliable predictive marker for COVID-19 severity and a potential marker of ARDS along with increased neutrophil/lymphocyte ratio.